US FDA okays Novartis drug to prevent liver transplant rejection Reuters The immune system drug, also known as everolimus, is already approved by the Food and Drug Administration for preventing organ rejection for kidney transplant patients. Regulators in Europe, where the drug is known as Certican, approved the liver ... |
